Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock (TTWO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.11 (market cap $3.94B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $201.5 (market cap $37.46B). The key difference: TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock is far larger — about 9.5× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock for 111 Days on average.
| EWTX | TTWO | |
|---|---|---|
Market Cap | $3.94B | $37.46B |
Volume | 810,104 | 5,201,670 |
Sector | Health | Technology |
52-Week High | $48.35 | $262.29 |
52-Week Low | $14.89 | $189.69 |
Typical Hold Time | 0 Days | 111 Days |
Enterprise Value | $3.48B | $38.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Take-Two Interactive (TTWO) trades at $201.23, down 3.63% today amid mixed technical signals and volatile earnings performance. The stock shows strong analyst support with 79% buy ratings and a $292.30 consensus price target, representing 45% upside potential. Recent quarterly results have been inconsistent with two beats and one miss, while the company maintains anticipation for Grand Theft Auto VI's November 2026 launch. Fundamentals reveal significant losses with a -79.51% net margin in 2025, though revenue growth continues and cash position remains strong at $1.47 billion.
The investment case hinges on GTA VI's successful execution, with current valuation reflecting high expectations. While analyst optimism remains strong, investors face risks from execution missteps, competitive pressures, and the stock's premium valuation multiples. The substantial negative earnings and cash flow volatility require careful monitoring, though institutional ownership trends show continued confidence in the long-term gaming franchise strategy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock
Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
Read more on TTWO →
